# Perrigo Company plc (PRGO) FY2026 Q2 Revenue by Business Segment

- Company: Perrigo Company plc (PRGO)
- Statement: Perrigo Company plc (PRGO) FY2026 Q2 P&L / Income Statement, https://plicit.ai/financials/prgo/fy2026-q2-income-statement
- Period: 2026-03-29 to 2026-06-27
- Filing: Q2 FY2026 10-Q, filed 2026-08-05, accession number 0001585364-26-000145
- Page: https://plicit.ai/financials/prgo/fy2026-q2-income-statement/revenue-by-business-segment
- Chart image: https://plicit.ai/charts/prgo-fy2026-q2-revenue-by-business-segment-sankey.png

## Chart details: Revenue by Business Segment

Income statement for 2026-03-29 through 2026-06-27. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Net sales**: 1,022,800,000 US dollars
- **Cost of sales**: 708,900,000 US dollars
- **Gross profit**: 313,900,000 US dollars
- **Total operating expenses**: 290,500,000 US dollars
- **Operating income (loss)**: 23,500,000 US dollars
- **Other income (expense), net (calculated)**: 81,900,000 US dollars
- **Income from continuing operations before taxes**: 105,400,000 US dollars
- **Income tax expense (benefit)**: 16,900,000 US dollars
- **Net income (loss)**: 74,500,000 US dollars
- **Self Care**: 576,600,000 US dollars
- **Specialty Care**: 226,600,000 US dollars
- **Infant Formula**: 100,900,000 US dollars
- **Rounding (calculated)**: 100,000 US dollars
- **Impairment charges**: 1,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn.
- **Other operating expense, net**: 0 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn.
- **Research and development**: 23,700,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn.
- **Distribution**: 21,700,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn.
- **Restructuring**: 14,400,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn.
- **Administration**: 100,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn.
- **Selling**: 129,500,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn.
- **Revenue before reconciliation (calculated)**: 904,200,000 US dollars. Sum of the reported revenue categories before the separately reported reconciliation.
- **All Other**: 118,600,000 US dollars. Reported reconciliation to consolidated revenue.
- **Loss from discontinued operations, net of tax**: negative 14,100,000 US dollars. Reported below-tax contribution to net income.

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit, plus the explicitly reported below-tax contributions, equals net income.
- Reported revenue categories plus the separately reported signed reconciliation equals consolidated revenue.
- The amounts that make up operating profit come to $23.40 M and operating profit is $23.50 M; the $0.10 M difference is within the rounding of the filed amounts.
- The amounts that make up net income come to $74.40 M and net income is $74.50 M; the $0.10 M difference is within the rounding of the filed amounts.

## Key Takeaways

- Specialty Care's operating income fell $18.50 M from a year earlier, to $47.80 M.
- Self Care brought in 56% of sales, but its operating income slid to $78.70 M from $93.90 M.
- Infant Formula swung to a $4.00 M operating profit from a $12.20 M loss, on 23% sales growth.
- Head-office costs and other items took about 82% of what the businesses earned.

## The Unvarnished Truth

### Specialty Care profit fell $18.50 M as Perrigo's segments lost ground

Perrigo's three businesses earned $130.50 M of operating income this quarter, down from $148.00 M a year earlier, and Specialty Care took the biggest hit. Its operating income fell $18.50 M to $47.80 M. Management blames "unfavorable gross profit flow through" from prior-year manufacturing volume headwinds and unfavorable mix, plus $4.0 million more spent on advertising to support second half growth initiatives. Self Care, which brings in 56% of sales, also slipped, to $78.70 M from $93.90 M. Only Infant Formula improved, swinging to a $4.00 M profit.

Why is Self Care slipping? Management cites "unfavorable net pricing impacts and lower consumption across both the U.S. and Europe", partly from a weaker cough and cold season that left retailers holding less inventory. Its sales fell 3.7% from a year earlier, gentler than the 12% drop of the quarter before. Infant Formula sales jumped 23%, but management credits mainly the "timing of contract infant formula shipments". Timing gains can reverse in a later quarter. And All Other lost $24.10 M of sales, largely because it held the Dermacosmetics business sold in April 2026.

For investors, mix matters: Specialty Care keeps about 21% of its sales as operating income and Infant Formula about 4.0%, so formula's growth does little for profit. The businesses' combined margin fell to 14.4% from 16.2%. In Self Care, management points to "benefits from the Operational Enhancement Program" cutting operating expenses by $12.0 million, yet head-office costs and other items still took about 82% of segment profit. Watch Self Care pricing and whether extra advertising lifts Specialty Care. If that advertising push fails, where does Perrigo's profit growth come from?

## Intelligent Insights for Investors

### Which of Perrigo's businesses drove its profit change over the past year?

Specialty Care, above all: its operating income fell $18.50 M from a year earlier, more than the $17.50 M drop in its businesses' combined operating profit. Infant Formula moved the other way, swinging to a $4.00 M profit.

### How profitable is each of Perrigo's businesses?

Specialty Care is the richest, keeping about 21% of sales as operating income this quarter, while Infant Formula kept just 4.0%. Self Care sits between, at 13.6%.

## Intelligent Insights for Employees

### Which of Perrigo's businesses brings in the most sales?

Self Care: it brought in 56% of Perrigo's sales this quarter, against 22% for Specialty Care, the next largest.
